CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS - Get Free Report) is expected to be releasing its Q4 2024 earnings data before the market opens on Wednesday, February 12th. Analysts expect CVS Health to post earnings of $0.89 per share and revenue of $96.90 billion for the quarter. CVS Health has set its FY 2025 guidance at 5.750-6.000 EPS.Parties interested in listening to the company's conference call can do so using this link.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. On average, analysts expect CVS Health to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

CVS Health Price Performance

CVS traded up $3.13 during trading on Thursday, hitting $66.35. 20,979,362 shares of the stock traded hands, compared to its average volume of 13,552,286. The business has a 50 day moving average price of $50.71 and a 200 day moving average price of $55.94. The company has a market cap of $83.49 billion, a price-to-earnings ratio of 16.84, a PEG ratio of 0.60 and a beta of 0.61. CVS Health has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. CVS Health's dividend payout ratio is currently 72.68%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CVS. Piper Sandler dropped their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a report on Monday, November 25th. Wells Fargo & Company increased their price objective on shares of CVS Health from $68.00 to $73.00 and gave the company an "overweight" rating in a research note on Thursday. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Barclays upped their price target on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday. Finally, Royal Bank of Canada cut their price objective on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $70.28.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.